Fact Check: Pfizer is planning on mutating viruses
New Project Veritas Video.
Update - Pfizer Responded
Their response is printed in full below.
Is Pfizer mutating viruses?
Below is the latest Project Veritas Video (you have to watch it now on Project Veritas as the video has been banned from Youtube). According to this employee of Pfizer, Pfizer is exploring making mutations of the Covid-19 virus, experimenting on live monkeys to do this.
Who is Jordon Trishton Walker?
His name is Jordon Trishton Walker and his job title at Pfizer currently Director, Worldwide R&D Strategic Operations and mRNA Scientific Planning. This does put his comments in a different light - if Pfizer was doing these things then it is his job as a middle manager to oversee at least a small part of these kinds of activities.
At least partly verified information.
At least part of the video has been verified by Pfizer – the gain of function research, which Pfizer says is not gain of function but research “where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern”.
Jordon Trishton Walker in the second video says was lying to impress his ‘date’, linked to at the end of the article (his ‘date’ is the Project Veritas journalist who was secretly filming Walker’s outrageous inebriated monologue). But which of Jordon Walker’s lies do we believe? Perhaps he was lying when he said he was lying?
Indeed, this whole thing is a mess of lies, and brings to mind Epimenides’ paradox (Epimenides, a Cretan himself, said “all Cretans are liars”):
firstly, Pfizer itself is a proven liar: Justice Department Announces Largest Health Care Fraud Settlement in Its History- Pfizer to Pay $2.3 Billion for Fraudulent Marketing (2009).
Secondly, Jordon Walker is either lying, or lying about lying.
Thirdly, the Project Veritas journalist essentially deceived Jordon Walker into revealing this stuff, which is a deceit we should be thankful for; thank God they exist to expose these large organisations which think they are above the law, above our democracies, and above ordinary people.
The Claims
From Project Veritas:
Jordon Trishton Walker, Pfizer Director of Research and Development, Strategic Operations - mRNA Scientific Planner: “One of the things we're exploring is like, why don't we just mutate it [COVID] ourselves so we could create -- preemptively develop new vaccines, right? So, we have to do that. If we're gonna do that though, there's a risk of like, as you could imagine -- no one wants to be having a pharma company mutating f**king viruses.”
Walker: “Don’t tell anyone. Promise you won’t tell anyone. The way it [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them.”
Walker: “You have to be very controlled to make sure that this virus [COVID] that you mutate doesn’t create something that just goes everywhere. Which, I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere. It’s bullsh*t.”
Walker: “From what I’ve heard is they [Pfizer scientists] are optimizing it [COVID mutation process], but they’re going slow because everyone is very cautious -- obviously they don’t want to accelerate it too much. I think they are also just trying to do it as an exploratory thing because you obviously don’t want to advertise that you are figuring out future mutations.”
Full Transcript of Jordon Walker’s confessions in the Project Veritas Video.
(some repetition; interesting things in bold; skip to the rest of the article below if you like )
Journalist: Pfizer ultimately is thinking about mutating COVID?
Walker: Well, that's not what we say to the public no. No. Don’t tell anyone this by the way, you have to promise you won’t tell anyone. We’re exploring like – you know - how the virus keeps mutating?
Journalist: Yeah.
Walker: Well one of the things we’re exploring is, like, why don’t we just mutate it ourselves so we could pre-emptively develop new vaccines, right? So, we have to do that. If we’re gonna do that though there's a risk of like, as you could imagine, no one wants to be having a pharma company mutating f-ing viruses. You have to be like very controlled to make sure that this virus that you mutate doesn’t create something like, you know, goes everywhere.
Journalist: So, man, crazy.
Walker: Which, I suspect is the way that the virus started in Wuhan, to be honest. Like, it makes no sense that this virus popped out of nowhere.
Journalist: Yeah, I know. It sounds like Gain-of-Function to me.
Walker: I don’t know, it’s a little bit different. I think it’s different. It’s like, this, it’s definitely not Gain-of-Function.
Journalist: It sounds like it is, I mean, it’s okay.
Walker: No, no, no, but directed evolution is very different. Well you’re not supposed to do Gain-of-Function research with the viruses. They’d rather we not, but we do these selected structure mutations to try to see if we can make them more potent. So, there is research ongoing about that. I don’t know how that’s going to work. There better not be any more outbreaks, cause, like, Jesus Christ.
Walker: It is a revolving door for all government officials. It’s pretty good for the industry to be honest.
Journalist: Yeh.
Walker: It’s bad for everyone else in America
Journalist: Why is it bad for everybody else?
Walker: Because if the regulators, who review our drugs, you know that once they stop being a regulator, they want to go work for the company, they are not going to be as harsh on the company where they’re getting their job.
Journalist: What is Pfizer doing, I guess, to optimize, you know, the vaccines now?
Walker: Ohhhh we actually had a meeting about that today, so there's a lot.
Journalist: Really?
Walker: We're doing, haha, I don't know if I should say this. (Laughs)
The journalist asked how Pfizer is dealing with the ineffectiveness of the vaccines.
Walker: We’re exploring like – you know how the virus keeps mutating?
Journalist: Yeah.
Walker: Well one of the things we’re exploring is, like, why don’t we just mutate it ourselves so we could pre-emptively develop new vaccines, right? So, we have to do that; if we’re gonna do that, though, there's a risk of like, as you could imagine, no one wants to be having a pharma company mutating f-ing viruses. So, we’re like, do we want to do this? So that’s like one of the things we’re considering. For, like, the future, like maybe we can like, create new versions of the vaccines and things like that.
Journalist: So Pfizer ultimately is thinking about mutating COVID?
Walker: Well, that is not what we say to the public, no, that’s what it was, it was a thought that came up in a meeting, and we were like, why do we not – it was like, we’re going to consider that, with more discussions.
Journalist: Okay.
Walker: Exactly, actually. We’re like, wait a minute, like, people won’t like that.
They were internally discussing mutating the virus.
Walker: So the way that we're thinking about it - don't tell anyone this by the way. You have to promise you won’t tell anyone, okay? So, um, the way it would work is like we put them in – the virus in these monkeys. And then we successively, like, cause them to keep infecting each other. And we collect serial samples from them, and then, the ones that are more infectious, to like, the virus, we'll put them in another monkey and you just constantly actively mutate it; that’s one way. Or we could even do like, directed like simulation, which like, we tend not to prefer. And they just sample what the different like, proteins on the surface of the virus look like over time.
Journalist: Okay.
Walker: So, then you can see the mutation. You can now force it to mutate in a certain way that you want it.
Journalist: Okay.
Walker: But you have to be, like, very controlled to make sure that this virus that you mutate doesn’t create something like, you know, goes everywhere.
Journalist: That’s completely crazy.
Walker: Which, I suspect is the way that the virus started in Wuhan, to be honest. Like, it makes no sense that this virus popped out of nowhere.
Journalist: Yeah, I know.
Walker: It’s bulls-t.
Journalist: So, I mean, when is Pfizer going to implement the mutation of all these viruses?
Walker: I don't know, it depends on how the experiments work out because this is just like, something we’re trying, right?
Journalist: It sounds like Gain-of-Function to me.
Walker: I don't know, it's a little bit different. I think it's different. It's like, this, it’s definitely not Gain-of-Function.
Journalist: It sounds like it is, I mean, it’s okay.
Walker: No, no, no, but directed evolution is very different.
Journalist: Direct evolution?
Walker: Directed evolution.
Journalist: Directed evolution, okay. (Walker giggles)
Journalist: Well, so, I mean, is that what it is?
Walker: Maybe, I don’t know (laughs). Well you’re not supposed to do Gain-of-Function research with the viruses. They’d rather we not, but we do these selected structure mutations to try to see if we can make them more potent. So, there is research ongoing about that. I don’t know how that’s going to work. There’d better not be any more outbreaks, cause, like, Jesus Christ.
Journalist: So, tell me more, like, what's developing with the whole, you know, virus mutation process?
Walker: Well, they are still kind of conducting the experiments on it, but… ah, it seems like, from what I’ve heard, they’re kind of optimising it, but they're going slow cause everyone’s very cautious, like, you know, obviously they don’t want to accelerate it too much. But I think they’re also just trying to do it as an exploratory thing because you obviously don't want to advertise that you are trying to figure out future mutations.
Journalist: So, did that – did the whole virus mutation thing come from your executive Sarah ? (Sarah Wu, third in command under Bourla)
Walker: No, that came from – we have like chief scientific officers in the other divisions.
Subsequent meeting - asked if this kind of gain of function research is going on at Pfizer. Answer was, no, so long as it’s called directed evolution, Pfizer is in the clear.
Journalist: What’s the goal for Pfizer doing that?
Walker: So, part of what they want to do is to try to figure out - to some extent, try to figure out like, you know there's all these new strains and variants that just pop up? Why don't we try to like catch them before they pop up in nature and we can develop a vaccine prophylactically, before, like new variants. So, that's why they're thinking like, if you do it controlled in a lab, then we say this is a new epitope, and so if it comes out later on, in the public, then you already have a vaccine kind of working.
Journalist: Oh my God. That's perfect. Isn't that like the best business model though? Just control nature before nature even happens itself, right?
Walker: Yeah, if it works.
Journalist: What do you mean if it works?
Walker: Because some of the times there are mutations that pop up that we are not prepared for, like with Delta and Omicron and things like that, so. Who knows? - I mean, either way, it’s going to be a cash cow. COVID will probably be a cash cow for us for a while going forward. Like, obviously, like…(laughs)
Journalist: Well I think the whole, you know, like, research of the viruses and mutating it, like, would be the ultimate cash cow.
Walker: Yeah, it’d be perfect.
You’d think creating viruses for new vaccines would be illegal.
Walker: It [Pfizer] is a revolving door for all government officials.
Journalist: Wow!
Walker: Yeah, for any industry though. So, in the pharma industry, all the government officials who, you know, review our drugs, eventually come work for pharma companies. And the military – all the army and defense government officials eventually go work for the defense companies afterwards.
Journalist: How do you feel about that revolving door?
Walker: It's pretty good for the industry to be honest. It's bad for everyone else in America.
Journalist: Why is it bad for everybody else [in America?]
Walker: Because if the regulators - who review our drugs, you know - that once they stop being a regulator, they want to go work for the company, they are not going to be as harsh on the company where they are getting their job.
The second video (below)
The second video just came out 27 Feb 2023. His “date” is the project veritas undercover reporter - this is how project Veritas catches their prey- honey pot essentially.
In that video he says, “I am literally a liar” and claims that everything he said was exaggeration in order to impress his date.
Here is the second video where Jordon Walker recapitulates Epimenides’ paradox and claims he is a liar; I guess if you want to watch it, you had better do so before you tube removes this one as well:
Babylon Bee’s take on this:
Jessica Rose’s take on this.
Jessica Rose, an expert in cell biology and a bunch of other related areas in her substack examines his speech and gives her assessment of his veracity:
Clearly the man in the video is not cogent enough to be speaking on subject matter related to serial passage of viruses1, for example. He certainly shouldn’tbe doing so to someone outside of his work-place, even if that someone was an ex-Pfizer employee. I think Pfizer probably have stacks of Non-Disclosure Agreements (NDA) that legally de-permit employees from talking about the natures of their jobs to the public, and outside of the workplace at all. And this man certainlyshould notbe disclosing aspects of this work in bar/restaurant, presumably to a newly-made mate, while intoxicated.
Jessica then says that Project Veritas entices people to make these revelations, and makes the point that we should “always behave in a way that would make your momma happy and proud of you, if she was watching/listening.”
The man in the PV video carries the title: Pfizer Director of Research and Development - Strategic Operations and mRNA Scientific Planning. My perception is that, it’s not what he is saying in the video that is one of the ‘tells’, but how he’s saying it. He says things in a way that reveals (to me, at least), that his role in his impressively-titled position, is limited.
She basically says he probably doesn’t know what he is talking about:
So, in a perfect societal set-up where his role is not limited to being a front man or a patsy, this man would know a whole lot about modified mRNA, methodologies like attenuation of viruses via serial passage, natural recombination in secondary hosts and classic DNA recombination laboratory-based techniques, and this is simply based on what he, himself, mentions in this video. He would be so well-versed in these subject matters that it would enable him to be the guy that explains all this lab stuff to bureaucrats and ‘executives’. In my opinion, by the way, the only way to be this level of well-versed in these kinds of lab techniques, etc. is to have done them first-hand. Experience is always the best teacher. We would all hope that someone who holds a title like his knows their stuff, right? Does he seem like he does? To me, he does not.
You will need to watch the video now on Project Veritas’ page:
for the video has been removed by youtube after 800,000 views, which speaks to its veracity:
Youtube(google)’s reason for removing this video (which had received 800,000 views) and giving Project Veritas a strike is that they say “Medical misinformation: youtube does not allow claims about covid-19 vaccinations that contradict expert consensus from local health authorities of WHO”.
Pfizer is in turmoil
According to sources inside Pfizer who talked to James O’Keefe, Pfizer is in turmoil, in damage control mode.
I feel a little sorry for Jordon Walker actually - I thought from his body language he seemed to have a few qualms about what Pfizer are doing… But maybe that was moral qualms about lying to impress his date? Or breaking his non-disclosure agreement with Pfizer? Well, if he did really have moral qualms about working for Pfizer, he’ll probably be happier and more at-peace when he loses his job.
Jordon Trishton Walker is a real person
Researcher Brian O’Shea (link below) looked into Jordon Walker’s presence on the internet and found he was a resident physician in the General Hospital Harvard Urologic Surgery Residency Program at Massachusetts General Hospital from 2018-2019, then became a consultant at BCG in Houston, a consulting company that does forecasts for big pharma companies and US Federal Health Agencies, and in May 2021 was employed by Pfizer. I've listed the job descriptions below that Brian O’Shea found.
Pfizer Organisational chart
Google knows nothing
Many of the links are being deleted from the net, and google allegedly suddenly finds nothing about Jordon Trishton Walker at all, according to some screen shots someone did soon after the story broke.
Addendum: I couldn’t verify this claim. Now google says it is a ‘developing story’, presumably in response to people pointing out that they initially had ‘lost or misplaced’ everything about Jordon Trishton Walker.
Jordon Trishton Walker CV
From https://brianoshea.substack.com/p/who-is-jordon-trishton-walker
NAME: Jordon Trishton Walker, M.D.
AKAs: Jordon Walker; Trishton Lee; Trishton Lee Walker; Jordon Walker; Joran Trishtan Lee Walker
Profession: Physician, Consultant.
Licensed in New York:
EXPERIENCE:
May 2021 - current: Director, Worldwide R&D Strategic Operations and mRNA Scientific Planning (Pfizer, Oct 2019 - Present)
May 2021 Consultant, Houston, TX; Boston, MA; (Boston Consulting Group “BCG”)
Biopharma growth strategy – Developed 5-year growth strategy for a large biopharma;
Created in-depth market and revenue forecast to support recommendations for investment in prioritized therapeutic areas to CEO and Board of Directors Oncology Diagnostic strategy;
Worked with cross functional and matrix team of senior executives to develop Precision Medicine strategy and clinical development plan for oncology pipeline assets;
Performed diligence to recommend strategic partnership with leading medical device companies Value-Based Payment Models;
Conducted impact evaluation of Value-Based Payment models and COVID-related changes in hospital reimbursement policies for a US federal health agency;
Participated in BCG sponsored Mandarin language and business immersion (Nov - Dec 2019)
May 2018 - Oct 2019: Urology Resident Physician, Greater Boston Area, Massachusetts (General Hospital Harvard Urologic Surgery Residency Program at Massachusetts General Hospital,
Jun 2013 - Jun 2014: Analyst, (Greater New York City Area, IQVIA)
Evaluated the projected profitability of therapeutic candidates for pharmaceutical companies;
Developed commercialization strategies for pharmaceuticals in development pipelines.
Education
UT Southwestern Medical Center;
Doctor of Medicine (M.D.)
Yale University;
Bachelors of Science; Molecular, Cellular, and Developmental Biology
Certifications
State of New York Physician License: 313466 (active and current)
License No: 313466
“Signal Hire” Profile: “Jordon Walker, M.D. Director, Worldwide R&D Strategic Operations and mRNA Scientific Planning at Pfizer. New York, New York, United States”
Pfizer docs verifying Jordon Walker’s position
Project Veritas got hold of Pfizer docs verifying his position.
Pfizer Responds
Pfizer did not mention the unfortunate Jordon Walker, but they have responded to the claims. I have quoted it in full below. https://www.pfizer.com/news/announcements/pfizer-responds-research-claims
The bolded sections in paragraph 2 and 3 are interesting admissions…
New York, N.Y., January 27, 2023 – Allegations have recently been made related to gain of function and directed evolution research at Pfizer and the company would like to set the record straight.
In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research. Working with collaborators, we have conducted research where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern. This work is undertaken once a new variant of concern has been identified by public health authorities. This research provides a way for us to rapidly assess the ability of an existing vaccine to induce antibodies that neutralize a newly identified variant of concern. We then make this data available through peer reviewed scientific journals and use it as one of the steps to determine whether a vaccine update is required.
In addition, to meet U.S. and global regulatory requirements for our oral treatment, PAXLOVID™, Pfizer undertakes in vitro work (e.g., in a laboratory culture dish) to identify potential resistance mutations to nirmatrelvir, one of PAXLOVID’s two components. With a naturally evolving virus, it is important to routinely assess the activity of an antiviral. Most of this work is conducted using computer simulations or mutations of the main protease–a non-infectious part of the virus. In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus. It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.
Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease.
Also as Jo Nova points out, if the coronavirus really was as deadly as they have been saying all along, one would think they would be doing those tests (second bolded section) in the BSL 4 labs, the highest biosecurity level.
The Coffee & Covid analysis of the wording of the Pfizer press release (Hat Tip LH.) was certainly helpful, in alerting me to a few extra points.
What was clear to me from Rand Paul’s questioning of Fauci in July 20, 2021 was that what the NIH (and therefore probably Pfizer, for they are hand-in-glove) calls gain of function is only specifically modifying a virus with the overtly stated intent to make it more infectious to humans: modifying a virus in a way that might make it more infectious to humans (e.g. by modifying a virus to make it more transmissible to mice with human ACE2 receptors, thereby ‘inadvertently’ making it more transmissible to humans <kof kof> ) is (rather deceitfully) not called gain of function (at least according to Fauci ), and in my opinion Pfizer confirms this definition by describing their research thus:
In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine, Pfizer has not conducted gain of function or directed evolution research. Working with collaborators, we have conducted research where the original SARS-CoV-2 virus has been used to express the spike protein from new variants of concern.
This is precisely the type of research that probably produced the SARS-CoV-2 virus in the first place; see “Viral” by Alina Chan and Matt Ridley which lays out the copious evidence that this is the case, and my article transgenic mice and chimeric viruses.
Coffee & Covid points out that Pfizer does not mention their affiliates or subcontractors in this statement, quote:
Pfizer has not conducted gain of function or directed evolution research.
This omission certainly is significant and is almost certainly an indicator of guilt, and implies that they are perfectly aware of EcoHealth alliance’s contribution to the creation of viruses in Wuhan, verifiably in the same family branch as COVID-19.
Coffee & Covid also says Pfizer have a lab in Israel, and that in Israel there are no laws prohibiting gain of function. Pfizer do indeed have laboratories in Israel - one particular new lab that is a partnership between AstraZeneca, Merck, Pfizer, Teva, Amazon Web Services and Israel Biotech Fund that uses AI and computational science to streamline drug development.
I have looked into Israel’s laws against gain of function research; the Israeli legislation merely limits who may possess dangerous pathogens to scientists and researchers approved by the Israeli Council for Monitoring Biological Disease Agents Research. In addition the US does not have laws prohibiting US companies from doing gain of function research overseas, despite legislation being put forward in 2021.
The bolded sentence in this part of the statement means they are forcing mutations to see if some viral mutations are resistant to their drugs:
In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. In addition, in vitro resistance selection experiments are undertaken in cells incubated with SARS-CoV-2 and nirmatrelvir in our secure Biosafety level 3 (BSL3) laboratory to assess whether the main protease can mutate to yield resistant strains of the virus. It is important to note that these studies are required by U.S. and global regulators for all antiviral products and are carried out by many companies and academic institutions in the U.S. and around the world.
This is actually what I would call forced evolution, and it should be completely illegal.
The whole of Israel is a Covid lab
Incidentally, Pfizer Vice-President, Philip Dormitzer, called the whole of Israel a COVID Vaccine laboratory in a statement in September 2021. Dormitzer said, “Early in the pandemic we established a relationship with the Israeli Ministry of Health where they used exclusively the Pfizer vaccine and then monitored it very closely, so we had a sort of laboratory where we could see the effect.”
Pfizer CEO Albert Bourla also said the same thing. “I believe Israel has become the world's lab right now because they are using only our vaccine at this state and they have vaccinated a very big part of their population, so we can study both economy and health indices… What we've seen is that the vaccine efficacy in real-world data is getting higher as we speak, following the second vaccination, so seven days compared to 14 days post-second vaccination, there is a difference in efficacy," Bourla claimed. In reply to the question of whether a person could infect others after receiving two doses, he said: "It is something that needs to be confirmed, and the real-world data that we are getting from Israel and other studies will help us understand this better. But there are a lot of indicators right now that are telling us that there is a protection against the transmission of the disease."
Of course, we know now that right at the start they were not even testing to find out if the vaccines stopped transmission.
Steve Bannon Interviews O’Keefe on the Video
The Australian popup link:
If you’re in Australia b t w you’ll get this helpful popup link on the first video so you can get the latest “medical information” from the Australian Government. (initially mistyped that as more accurately ‘misinformation’ .)
Here’s the delightful advice from the Australian health department that comes up:
Change Log -
done so many changes on this one today, mostly updates, a few to streamline and cut dross.
References (gain of function laws in Israel and US)
https://www.ima.org.il/FilesUploadPublic/IMAJ/0/99/49530.pdf
https://www.govtrack.us/congress/bills/117/hr4071
